Skip to main content
C

Citadel Group — Investor Relations & Filings

Ticker · CGL ISIN · AU000000CGL3 LEI · 213800FIHTDHRZIC4882 ASX Financial and insurance activities
Open in API
Filings indexed 2,056 across all filing types
Latest filing 2025-12-22 Regulatory Filings
Country AU Australia
Listing ASX CGL

About Citadel Group

https://www.citadelgroup.com.au/

Citadel Group is a software and technology company specializing in secure enterprise information management for complex environments. The firm develops and delivers software applications, digital platforms, managed services, and IT solutions. It primarily serves government departments and large corporate clients, with a focus on managing system-critical data. The company also provides solutions for the healthcare sector aimed at improving patient outcomes. The organization has evolved and now operates under the name Citadel Edge.

Recent filings

Filing Released Lang Actions
Form 8.3 - Avadel Pharmaceuticals plc
Regulatory Filings Classification · 1% confidence The document is a 'Form 8.3' filing, which is a standard regulatory disclosure required under the Irish Takeover Panel Act. It details an 'Opening Position Disclosure/Dealing Disclosure' by Citadel Group regarding their interests and dealings in the securities of Avadel Pharmaceuticals PLC. This is a specific regulatory filing related to takeover activity and shareholding positions, which falls under the 'Regulatory Filings' category as it is a mandatory disclosure to a Regulatory Information Service.
2025-12-22 English
Form 8.3 - Avadel Pharmaceuticals plc
Regulatory Filings Classification · 1% confidence The document is a 'Form 8.3' disclosure filed under the Irish Takeover Panel Act, 1997. This form is used by persons with interests in relevant securities representing 1% or more to disclose their positions and dealings in the context of a takeover offer (in this case, for Avadel Pharmaceuticals PLC). This type of filing is a standard regulatory requirement for major shareholders during M&A activity and does not fit into the other specific categories like 'Major Shareholding Notification' (which is for crossing thresholds) or 'Director's Dealing'. Therefore, it is classified as a Regulatory Filing (RNS).
2025-12-19 English
Form 8.3 - International Personal Finance plc
Regulatory Filings Classification · 1% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing under the UK Takeover Code. It details the opening position and dealings in relevant securities by a person with interests representing 1% or more. This type of document is a specific regulatory requirement for market transparency during takeover situations and does not fit into categories like Annual Reports, Earnings Releases, or Director's Dealings. Therefore, it is classified as a Regulatory Filing (RNS).
2025-12-19 English
Form 8.3 - International Personal Finance plc
Regulatory Filings Classification · 1% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing required under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree. It details share dealings and positions in International Personal Finance PLC by Citadel Group. Since this is a specific regulatory disclosure regarding shareholdings and market activity rather than a major shareholding notification (which usually refers to crossing thresholds like 3% or 5% under DTR rules) or a company-specific report, it falls under the 'Regulatory Filings' (RNS) category as the most appropriate fallback for this type of market surveillance disclosure.
2025-12-18 English
Form 8.3 - Avadel Pharmaceuticals plc
Regulatory Filings Classification · 1% confidence The document is a 'Form 8.3' disclosure filed under the Irish Takeover Panel Act, 1997. This form is used by persons with interests in relevant securities representing 1% or more to disclose their positions and dealings in the securities of an offeror or offeree during a takeover period. As this is a specific regulatory disclosure regarding shareholdings and derivative positions in the context of a takeover, it falls under the 'Regulatory Filings' category as the most appropriate fallback for this type of specialized financial disclosure.
2025-12-18 English
Form 8.3 - Avadel Pharmaceuticals plc
Regulatory Filings Classification · 1% confidence The document is a 'Form 8.3' filing, which is a standard regulatory disclosure required under the Irish Takeover Panel Act. It details an 'Opening Position Disclosure/Dealing Disclosure' by Citadel Group regarding their interests and dealings in the securities of Avadel Pharmaceuticals PLC. This type of document is a mandatory regulatory notification regarding significant shareholding and trading activity during a takeover period, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like 'Director's Dealing' (which is for company insiders) or 'Major Shareholding Notification' (which is for crossing specific ownership thresholds).
2025-12-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.